Therapies for hematologic malignancies
US10154998B2 · kind B2 · utility
0Cited by
60References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2016 |
| Grant date | Dec 18, 2018 |
| Priority date | — |
| Expiry date | Sep 27, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administering a compound of formula A,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.